Ci Medical Co., Ltd. (3540) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Vital KSK Holdings, Inc.

AS ONE Corp.

Paltac Corp.

Ci Medical Co., Ltd.

SHIP HEALTHCARE HOLDINGS, INC.

Arata Corp.

Alfresa Holdings Corp.

Medipal Holdings Corp.

Nagaileben Co., Ltd.

Toho Holdings Co., Ltd.

Nipro Corp.

Why is Ci Medical Co., Ltd. ?

High Management Efficiency with a high ROCE of 23.08%

Company has very low debt and has enough cash to service the debt requirements

Positive results in Jun 25

ROCE(HY) Highest at 33.76%
NET SALES(Q) Highest at JPY 23,476 MM
INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost

With ROCE of 8.84%, it has a attractive valuation with a 1.76 Enterprise value to Capital Employed

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 55.25%, its profits have risen by 28.3%

Market Beating Performance

The stock has generated a return of 55.25% in the last 1 year, much higher than market (Japan Nikkei 225) returns of 29.35%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Ci Medical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Retailing should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Ci Medical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Ci Medical Co., Ltd.

61.47%

1.05

46.97%

Japan Nikkei 225

28.54%

1.14

25.81%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

20.91%

EBIT Growth (5y)

3.58%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

1.26

Net Debt to Equity (avg)

0.18

Sales to Capital Employed (avg)

1.58

Tax Ratio

15.16%

Dividend Payout Ratio

10.00%

Pledged Shares

Institutional Holding

ROCE (avg)

23.08%

ROE (avg)

14.41%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.89

EV to EBIT

19.87

EV to EBITDA

11.25

EV to Capital Employed

1.76

EV to Sales

0.71

PEG Ratio

Dividend Yield

ROCE (Latest)

8.84%

ROE (Latest)

8.64%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bearish

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

36What is working for the Company

ROCE(HY)

Highest at 33.76%

NET SALES(Q)

Highest at JPY 23,476 MM

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

RAW MATERIAL COST(Y)

Fallen by -39.62% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at 5.78 %

INVENTORY TURNOVER RATIO(HY)

Highest at 4.86%

DEBTORS TURNOVER RATIO(HY)

Highest at 13.05%

PRE-TAX PROFIT(Q)

Highest at JPY 1,788 MM

NET PROFIT(Q)

Highest at JPY 1,134.15 MM

-11What is not working for the Company

INTEREST(HY)

At JPY 50 MM has Grown at 163.16%

Here's what is working for Ci Medical Co., Ltd.

Net Sales

At JPY 23,476 MM has Grown at 89.78%

Year on Year (YoY)

MOJO Watch

Near term sales trend is extremely positive

Net Sales (JPY MM)

Net Sales

Highest at JPY 23,476 MM and Grown

In each period in the last five periods

MOJO Watch

Near term sales trend is very positive

Net Sales (JPY MM)

Pre-Tax Profit

At JPY 1,788 MM has Grown at 234.83%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (JPY MM)

Net Profit

At JPY 1,134.15 MM has Grown at 239.72%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (JPY MM)

Pre-Tax Profit

Highest at JPY 1,788 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (JPY MM)

Net Profit

Highest at JPY 1,134.15 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (JPY MM)

Debt-Equity Ratio

Lowest at 5.78 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Inventory Turnover Ratio

Highest at 4.86%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 13.05%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -39.62% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Ci Medical Co., Ltd.

Interest

At JPY 50 MM has Grown at 163.16%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)